SOURCE: CISION PR Newswire
CDI Labs Launches New VirScan, HuScan, and MouseScan Services for Massively Multiplexed Analysis of Serum AntibodiesNew Services Use Phage Display Immunoprecipitation Sequencing (PhIP-Seq) to Provide Groundbreaking High-throughput, Proteome-wide Seromic Analysis
READ MORESOURCE: CISION PR Newswire
Barney E. Saunders Ph.D. has been appointed Chief Executive Officer of CDI Laboratories READ MORESOURCE: CISION PR Newswire
BroadOak Capital Partners Invests in CDI Laboratories to Expand and Scale Antibody Biomarker Discovery PlatformsThe investment will support the expansion of CD's technology platforms to service more customers.
READ MORESOURCE: CISION PR Newswire
CDI Labs HuProt™ Protein Arrays Instrumental in Recent Study of Multisystem Inflammatory Syndrome in Children (MIS-C)Proteomics company CDI Laboratories products used in important study of MIS-C and its relationship to SARS-CoV-2 (COVID-19) infection.
READ MORESOURCE: CISION PR Newswire
CDI Labs Launches Two New Powerful Assays to its Biomarker Discovery PlatformProteomics company CDI adds HuScan™ (PhIP-Seq patient biomarker discovery platform) and VirScan™ (PhIP-Seq antibody detection assays that includes every known human and viral protein).
READ MORESOURCE: CISION PR Newswire
CDI Labs to showcase immuno-oncology products & services at AACR 2019 READ MORESOURCE: CISION PR Newswire
CDI Labs Releases HuProt™ v4.0 - Adding additional content to Largest Content Human Proteome Microarray in the WorldProteomics company now producing glass slides printed with recombinant human proteins containing over 21,000 human proteins and protein isoforms, including >81% of canonically expressed proteins as defined by the Human Protein Atlas for high throughput analytics, contract research and hybridoma development services.
READ MORESOURCE: CISION PR Newswire
CDI Labs' Monoclonal Antibody Development Pipeline featured in Nature MethodsProteomics company leverages microarray capability to develop truly monospecific monoclonal antibodies
READ MORESOURCE: BioSpace
CDI Labs Collaborates on Discovery of New Biomarkers for Zika Infection READ MORESOURCE: CISION PR Newswire
CDI Labs Cites New Research Identifying Early Lung Cancer Autoantibody Biomarkers using HuProt™Proteomics company's high-content proteome microarray gaining traction in disease diagnosis and prognosis.
READ MORE1
2